What Is Ejection Fraction?
Ejection fraction (EF) is the percentage of blood pumped out of a ventricle with each heartbeat. In most everyday clinical discussions, EF refers to the left ventricle, the heart chamber that pumps oxygen-rich blood to the body. If the left ventricle fills with a certain amount of blood and ejects a portion of it during contraction, EF expresses that portion as a percentage.
For example, if a ventricle contains 120 mL of blood before contraction and 50 mL remain afterward, then 70 mL were ejected. The ejection fraction in that case is 70/120, or about 58%. EF is widely used because it is easy to communicate, easy to trend over time, and helpful when deciding treatment strategies for many cardiovascular conditions.
EF is not the same as cardiac output, blood pressure, or heart rate, although all are related to heart performance. A person can have a normal EF and still have heart-related symptoms. Likewise, some individuals with reduced EF may feel relatively stable for long periods when appropriately treated.
How to Calculate Ejection Fraction
The standard formula is:
EF = ((EDV − ESV) / EDV) × 100
- EDV (End-Diastolic Volume): Blood volume in the ventricle at the end of filling (diastole).
- ESV (End-Systolic Volume): Blood volume remaining after contraction (systole).
- Stroke Volume: EDV − ESV.
Because EF is a percentage, it adjusts for different chamber sizes and allows useful comparison between measurements over time. However, EF still depends on measurement quality and loading conditions such as hydration status, blood pressure, valve function, and rhythm.
Normal and Abnormal EF Ranges
Different labs and imaging modalities may use slightly different reference ranges. A commonly used framework is below:
| EF Range | Clinical Meaning (General) | Possible Interpretation |
|---|---|---|
| 55% to 70% | Often considered normal | Systolic pumping function generally preserved |
| 50% to 54% | Borderline low-normal in some contexts | May warrant trend monitoring with symptoms and risk factors |
| 41% to 49% | Mildly reduced | Can align with mildly reduced systolic function |
| 40% or below | Reduced EF | Often associated with heart failure with reduced ejection fraction (HFrEF) when symptoms/signs are present |
| Above 70% | Hyperdynamic in some situations | May occur with high sympathetic tone, small cavity size, or specific physiologic/pathologic states |
Ranges are useful for screening and communication, but no single number can replace full clinical context. Interpretation should always include symptoms, exam findings, imaging details, and relevant medical history.
Why Ejection Fraction Matters
EF influences prognosis, medication strategy, and long-term follow-up in many heart conditions. It can guide decisions such as the use of specific heart failure therapies, timing of repeat imaging, and in selected patients, device therapy.
When EF declines, the heart may struggle to maintain adequate forward flow during stress or even at rest. Over time, compensatory mechanisms can increase fluid retention, neurohormonal activation, and cardiac remodeling. Modern heart failure care aims to interrupt those pathways and protect heart function.
Tracking EF across months and years can reveal whether treatment is working, whether disease is progressing, or whether additional evaluation is needed. That said, symptom improvement can occur even without large EF changes, and sometimes EF improves substantially with treatment adherence.
Common Causes of Low Ejection Fraction
Reduced EF is a finding, not a diagnosis by itself. It can result from multiple conditions, including:
- Coronary artery disease and prior myocardial infarction (heart attack)
- Dilated cardiomyopathy (genetic, viral, inflammatory, toxic, or idiopathic)
- Longstanding uncontrolled hypertension
- Valvular heart disease (for example, severe regurgitation or stenosis)
- Myocarditis
- Tachycardia-induced cardiomyopathy from persistent fast arrhythmias
- Toxin-related injury (alcohol, certain chemotherapy agents, recreational drugs)
- Endocrine and metabolic conditions affecting myocardium
Because causes vary, evaluation typically includes detailed history, lab tests, electrocardiography, and imaging. In some cases, coronary imaging, cardiac MRI, stress testing, or genetic counseling may be recommended.
Symptoms Associated With Low EF
Symptoms can range from none to severe limitation. Common patterns include:
- Breathlessness on exertion or when lying flat
- Reduced exercise tolerance and fatigue
- Leg or ankle swelling
- Rapid weight gain from fluid retention
- Nocturnal cough or waking short of breath
- Palpitations, dizziness, or near-fainting episodes
If symptoms are new, worsening, or accompanied by chest pain, fainting, confusion, or severe breathing difficulty, urgent medical evaluation is important.
How EF Is Measured in Clinical Practice
Echocardiography (Ultrasound)
Echo is the most commonly used method. It is noninvasive, widely available, and useful for serial follow-up. Techniques may include 2D or 3D volume analysis and Simpson’s biplane method.
Cardiac MRI
Cardiac MRI is highly accurate for chamber volumes, EF, and tissue characterization. It is especially useful when echo windows are limited or when myocarditis, infiltrative disease, or scar burden are under evaluation.
Nuclear Imaging and CT
Nuclear ventriculography and gated perfusion studies can estimate EF and assess perfusion. Cardiac CT can provide structural details and sometimes functional estimates depending on protocol.
Important Measurement Considerations
EF can vary with heart rhythm, preload, afterload, blood pressure, and imaging quality. Small differences between tests do not always indicate true clinical change. Trends and overall clinical status are often more informative than one isolated value.
Treatment Options for Reduced EF
Management depends on cause, severity, and symptom burden. For many patients with heart failure and reduced EF, evidence-based medical therapy can significantly improve outcomes.
- Neurohormonal blockade and guideline-directed medications as clinically appropriate
- Diuretics for congestion and fluid symptoms
- Blood pressure optimization and rhythm management
- Coronary revascularization in selected ischemic cases
- Valve interventions when structural disease is contributing
- Device therapy (such as ICD/CRT) for specific indications
- Advanced therapies in severe, refractory cases
Treatment is individualized. Medication type, sequence, and dose should be determined by qualified clinicians who can monitor blood pressure, kidney function, electrolytes, and tolerability.
Lifestyle Strategies That Support Heart Function
Medical therapy is central, but daily habits strongly influence symptoms and long-term risk. Patients are often advised to:
- Limit sodium intake as directed by their care team
- Monitor fluid intake when recommended
- Track daily body weight and report rapid increases
- Follow a heart-healthy eating pattern emphasizing whole foods
- Engage in safe, regular physical activity or cardiac rehabilitation
- Avoid smoking and limit alcohol
- Take medications consistently and attend follow-up appointments
- Manage diabetes, blood pressure, sleep disorders, and kidney disease
These steps do not replace medical treatment, but they can improve quality of life, reduce decompensation risk, and support better long-term outcomes.
Limitations of Ejection Fraction
EF is useful, but it does not fully define heart health. Some patients with symptoms of heart failure have preserved EF. Others with reduced EF may function well day to day. EF also does not capture diastolic function, right ventricular performance, valve severity, pulmonary pressures, or myocardial strain by itself.
This is why cardiology assessments often include multiple data points: symptom profile, physical exam, natriuretic peptide levels, electrocardiography, imaging characteristics, and sometimes hemodynamic measurements.
In short, EF is an important marker, but it is one component of a broader clinical picture.
Frequently Asked Questions
Can ejection fraction improve over time?
Yes. Depending on the cause, EF may improve with targeted treatment, blood pressure control, rhythm correction, revascularization, toxin avoidance, and consistent follow-up. Some patients experience substantial recovery.
Is a normal EF proof that the heart is healthy?
No. A normal EF does not exclude all cardiac disease. Valve disorders, diastolic dysfunction, ischemia, arrhythmias, and other conditions can occur even when EF is preserved.
How often should EF be rechecked?
Timing depends on diagnosis, treatment stage, and symptom stability. Your clinician determines follow-up intervals, often after therapy changes or if symptoms evolve.
What should I do if my calculator result is low?
Use the result as informational only and discuss it with a healthcare professional. Clinical interpretation requires full context and, ideally, imaging-based measurement by trained providers.